EDAP to Present at the Jefferies Healthcare Conference
May 24, 2023 08:00 ET
|
EDAP TMS S.A.
LYON, France, May 24, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled...
EDAP Announces First Quarter 2023 Financial Results
May 17, 2023 06:30 ET
|
EDAP TMS S.A.
- Record first quarter revenue - - Positive results from two studies reconfirm safety and efficacy of Focal One - - Company to host conference call and webcast today, Wednesday, May 17that 8:30 am...
EDAP to Announce First Quarter 2023 Financial Results on May 17, 2023
May 03, 2023 08:00 ET
|
EDAP TMS S.A.
- Company to host conference call and webcast on Wednesday, May 17that 8:30 am EDT - LYON, France, May 3, 2023 - EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic...
EDAP Announces Major Presence at Upcoming Annual Meeting of the American Urological Association (AUA)
April 21, 2023 08:00 ET
|
EDAP TMS S.A.
Meeting to Showcase EDAP’s Focal One® Robotic High Intensity Focused Ultrasound (HIFU) Platform for the Management of Prostate Cancer LYON, France, April 21, 2023 -- EDAP TMS SA (Nasdaq:...
EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience
April 10, 2023 08:00 ET
|
EDAP TMS S.A.
Leading Center Demonstrates Focal HIFU as a Tool in The Management of Prostate Cancer Webcast scheduled for Tuesday, April 18th at 12:00 p.m. PDT (3:00 p.m. EDT) LYON, France, April 10, 2023 -- EDAP...
EDAP Announces Regulatory Clearance of ExactVu Micro-Ultrasound in Japan
April 06, 2023 08:00 ET
|
EDAP TMS S.A.
Allows for market launch of the only micro-ultrasound platform for precision prostate biopsies LYON, France, April 6, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), a global leader in...
EDAP Reports Record Fourth Quarter and Full-Year 2022 Results and Announces Leadership Succession Plan to Develop Global Group Strategy
March 30, 2023 06:30 ET
|
EDAP TMS S.A.
Record full-year 2022 total revenue of EUR 55.1 million ($58.0 million) increased 25.1% over full-year 2021Full-year HIFU revenue was EUR 15.6 million (USD 16.4 million), an increase of 57.7% as...
EDAP Presents Positive Results from Non-Inferiority Study Comparing Outcomes of Focal One HIFU Versus Radical Prostatectomy at EAU23
March 21, 2023 16:30 ET
|
EDAP TMS S.A.
Results demonstrate salvage treatment free survival rate (STFS) at 30 months of 90.1% in the HIFU-treated arm versus 86.8% in patients who underwent radical prostatectomy (RP) The HIFU...
EDAP to Announce Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30th
March 09, 2023 08:00 ET
|
EDAP TMS S.A.
LYON, France, March 9, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the...
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2022 Revenue
February 14, 2023 09:00 ET
|
EDAP TMS S.A.
Record full-year 2022 total preliminary unaudited revenue of €55.1 million ($58.0 million) represents an increase of 25.1% over full-year 2021, driven by 58.1% HIFU growth Record Q4 2022 total...